SHSE:688166'
s Days Inventory Range Over the Past 10 Years
Min: 159.76 Med: 219.93 Max: 272.19
Current: 221.75
During the past 10 years, Brightgene Bio-medical Technology Co's highest Days Inventory was 272.19. The lowest was 159.76. And the median was 219.93.
SHSE:688166's Days Inventory is ranked worse than 57.99% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs SHSE:688166: 221.75
Inventory Turnover measures how fast the company turns over its inventory within a year.
Brightgene Bio-medical Technology Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.39.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Brightgene Bio-medical Technology Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.11.
Brightgene Bio-medical Technology Co (SHSE:688166) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Brightgene Bio-medical Technology Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Brightgene Bio-medical Technology Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Brightgene Bio-medical Technology Co Days Inventory Related Terms
Brightgene Bio-medical Technology Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Brightgene Bio-medical Technology Co Days Inventory Chart
SHSE:688166 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Brightgene Bio-medical Technology Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Brightgene Bio-medical Technology Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Brightgene Bio-medical Technology Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Brightgene Bio-medical Technology Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Brightgene Bio-medical Technology Co (SHSE:688166) has a Days Inventory of 234.76 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Brightgene Bio-medical Technology Co and its competitors. This is near median its historical median of 219.93. Over the past decade, Brightgene Bio-medical Technology Co's Days Inventory has ranged from 159.76 to 272.19. According to the industry distribution chart, Brightgene Bio-medical Technology Co ranks #370 out of 638 companies in the Biotechnology industry, placing it in the top 58%.
Is Brightgene Bio-medical Technology Co's Days Inventory too high?
Brightgene Bio-medical Technology Co's current Days Inventory of 234.76 is near median its 10-year median of 219.93. Over the past 10 years, this metric has ranged from a low of 159.76 to a high of 272.19. The Biotechnology industry median Days Inventory is 183.20. Brightgene Bio-medical Technology Co's value of 234.76 is 28.1% above this industry median. Based on the distribution chart, Brightgene Bio-medical Technology Co ranks #370 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Brightgene Bio-medical Technology Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Brightgene Bio-medical Technology Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Brightgene Bio-medical Technology Co ranks #370 out of 638 companies for Days Inventory. This places Brightgene Bio-medical Technology Co in the lower half of its industry. The industry median Days Inventory is 183.20. Brightgene Bio-medical Technology Co's value of 234.76 is 28.1% above this benchmark. Historically, Brightgene Bio-medical Technology Co's own Days Inventory has ranged from 159.76 to 272.19 over the past decade. While the company's 10-year median is 219.93 vs. the industry median of 183.20, Brightgene Bio-medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Brightgene Bio-medical Technology Co's current Days Inventory of 234.76 is 28.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Brightgene Bio-medical Technology Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Brightgene Bio-medical Technology Co's current Days Inventory is 234.76, which is near median its own 10-year median of 219.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brightgene Bio-medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Brightgene Bio-medical Technology Co (SHSE:688166) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥38.50, compared to a current price of ¥29.84 — trading 22.5% below its estimated fair value. The current Days Inventory is 234.76, which is near median its 10-year median of 219.93 and 28.1% above the Biotechnology industry median of 183.20. Brightgene Bio-medical Technology Co's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Brightgene Bio-medical Technology Co (SHSE:688166), the current Days Inventory is 234.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Brightgene Bio-medical Technology Co (SHSE:688166) Overvalued in 2026?
Based on GuruFocus' analysis, Brightgene Bio-medical Technology Co stock appears to be undervalued.
The current stock price of ¥29.84 is trading 22.5% below its estimated GF Value™ of ¥38.50.
GuruFocus considers Brightgene Bio-medical Technology Co to be Modestly Undervalued.
Key valuation signals for SHSE:688166:
Days Inventory: 234.76 (near median its 10-year median of 219.93)
GF Value™: ¥38.50 vs. price of ¥29.84 (22.5% below fair value)
Industry Position: 28.1% above the Biotechnology median (#370 of 638)
No single metric tells the full story. See the SHSE:688166 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Brightgene Bio-medical Technology Co Business Description
Brightgene Bio-medical Technology Co Ltd is engaged in the Research and development and production of pharmaceutical intermediates, active pharmaceutical ingredients and formulations with high technological barriers.
82GF Score
Get the complete analysis for SHSE:688166
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688166 has been successfully added to your 
